ApaTech, a UK-based developer of orthopedic implants, has raised $45 million in a VC funding round co-led by HealthCor Partners and return backer 3i Group. The company had previously raised around $24 million, and says that it applies “the science of silicon to bone graft technology.”
CEO Simon Cartmell said “These funds allow us to continue the successful development of ApaTech into a world leading orthobiologics company. We see significant potential in Actifuse and the portfolio of new technologies we are developing and I am delighted we have been able to secure investment from, and involvement of, two world class financial institutions who clearly share our vision of the future.”
As a result of the investment the Board of Directors will change significantly. Peter Chambr